RecruitingACTRN12620001138976

Effectiveness of Hematoma block in acute pain management and closed reduction of fractures in children presenting to DHQ Kohat: An exploratory RCT


Sponsor

Khalid Rehman

Enrollment

150 participants

Start Date

Nov 12, 2019

Study Type

Interventional

Conditions

Summary

Hematoma block and Intravenous analgesia are both simple options, as none of these techniques require expertise or special equipments . Hematoma block is not compared with IV analgesia in children with fractures of lower segment of limbs before. In view of the above, a study is to be undertaken to evaluate the effects of hematoma block and Intravenous analgesic for closed reduction of fractures and for immediate pain relief in individuals.


Eligibility

Sex: Both males and femalesMin Age: 7 YearssMax Age: 14 Yearss

Plain Language Summary

Simplified for easier understanding

This study compares two methods of managing pain and performing a bone realignment procedure (closed reduction) for children with fractures of the forearm or lower leg bone. When a child breaks a bone and it needs to be straightened without surgery, pain relief is critically important. One method uses a 'hematoma block' — an injection of local anaesthetic directly into the fracture site — while the other uses intravenous (IV) pain medication. Both approaches are simple and don't require specialised equipment or training. The study aims to find out which is safer and more effective for children in terms of pain relief during the procedure and quality of the bone realignment. This research is being conducted in Pakistan at a district hospital setting. A child may be eligible if they are aged 7 to 14, have a closed (non-open) fracture of the forearm or shinbone that happened within the last 24 hours, requires realignment, and their parents and the child have provided consent and assent. Children with other medical conditions, joint fractures, fractures that don't need realignment, or multiple fractures are not eligible.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Hematoma block and intravenous analgesia are the two interventions which will be administered by the Surgeon. Patients will be randomized to one of the groups. Each patient will only recieve one inter

Hematoma block and intravenous analgesia are the two interventions which will be administered by the Surgeon. Patients will be randomized to one of the groups. Each patient will only recieve one intervention. The intervention will be administered immediately before the fracture reduction. Hematoma block: Fracture hematoma will be injected with 2% lignocaine in a dose of 0.5 ml/kg. Intravenous analgesia: Injection Ketorolac (Toradol) will be injected in the Cubital vein of the contralateral limb in a dose of 0.2 ml/kg.


Locations(1)

Khyber Pakhtunkhwa, Pakistan

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12620001138976


Related Trials